Regeneron Pharmaceuticals (REGN) Market Cap 1991–2026

As of October 29, 2026, Regeneron Pharmaceuticals had a market cap of $84.66 billion, which increased by 0.68% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals Inc. (REGN)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$84.66B ▲ 0.68%
Start of 2026
$81.12B ▲ 4.36%
1 Year Ago
$68.74B ▲ 23.16%
All-Time High
$132.47B ▼ 36.09%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Regeneron Pharmaceuticals Market Cap History by Year and Month

Regeneron Pharmaceuticals Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$84.66B▲ 4.36%
$84.66B▲ 7.97%
$78.41B▼ 5.10%
$82.62B▲ 4.77%
$78.86B▲ 20.45%
$65.47B▲ 1.58%
$64.45B▼ 13.06%
$74.13B▼ 9.24%
$81.68B▼ 1.16%
$82.64B▲ 6.04%
$77.93B▼ 3.93%
2025$81.12B▲ 3.89%
2024$78.086B▼ 18.40%
2023$95.69B▲ 21.79%
2022$78.57B▲ 14.49%
All market cap values reflect closing prices for the period shown.

📊 Regeneron Pharmaceuticals Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $136.81B
  2. $88.88B
  3. $84.66B
  4. $62.61B
  5. $40.76B
  6. $36.9B
  7. $27.11B
  8. $25.33B
  9. $24.36B
  10. $23.47B
  11. $23.27B
  12. $16.48B
  13. $14.96B
  14. $14.87B
  15. $13.81B
  16. $12.85B
  17. $11.13B
  18. $10.21B
  19. $10.15B
  20. $9.97B


Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.